These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16522516)

  • 21. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 3: synthesis of cyclopentanone and cyclohexanone intermediates for C-ring modification.
    Richardson TI; Dodge JA; Durst GL; Pfeifer LA; Shah J; Wang Y; Durbin JD; Krishnan V; Norman BH
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4824-8. PubMed ID: 17614275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Agonist activity of the 3-hydroxy metabolites of tibolone through the oestrogen receptor in the mouse N20.1 oligodendrocyte cell line and normal human astrocytes.
    Guzmán CB; Zhao C; Deighton-Collins S; Kleerekoper M; Benjamins JA; Skafar DF
    J Neuroendocrinol; 2007 Dec; 19(12):958-65. PubMed ID: 18001325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural aspects of agonism and antagonism in the oestrogen receptor.
    Pike AC; Brzozowski AM; Walton J; Hubbard RE; Bonn T; Gustafsson JA; Carlquist M
    Biochem Soc Trans; 2000; 28(4):396-400. PubMed ID: 10961927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta.
    Minutolo F; Bertini S; Granchi C; Marchitiello T; Prota G; Rapposelli S; Tuccinardi T; Martinelli A; Gunther JR; Carlson KE; Katzenellenbogen JA; Macchia M
    J Med Chem; 2009 Feb; 52(3):858-67. PubMed ID: 19128016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of ligands with bicyclic scaffolds provides insights into mechanisms of estrogen receptor subtype selectivity.
    Hsieh RW; Rajan SS; Sharma SK; Guo Y; DeSombre ER; Mrksich M; Greene GL
    J Biol Chem; 2006 Jun; 281(26):17909-19. PubMed ID: 16648639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen receptor microarrays: subtype-selective ligand binding.
    Kim SH; Tamrazi A; Carlson KE; Daniels JR; Lee IY; Katzenellenbogen JA
    J Am Chem Soc; 2004 Apr; 126(15):4754-5. PubMed ID: 15080660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics.
    Celik L; Lund JD; Schiøtt B
    Biochemistry; 2007 Feb; 46(7):1743-58. PubMed ID: 17249692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats.
    Hummel CW; Geiser AG; Bryant HU; Cohen IR; Dally RD; Fong KC; Frank SA; Hinklin R; Jones SA; Lewis G; McCann DJ; Rudmann DG; Shepherd TA; Tian H; Wallace OB; Wang M; Wang Y; Dodge JA
    J Med Chem; 2005 Nov; 48(22):6772-5. PubMed ID: 16250633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-based virtual screening for plant-based ERbeta-selective ligands as potential preventative therapy against age-related neurodegenerative diseases.
    Zhao L; Brinton RD
    J Med Chem; 2005 May; 48(10):3463-6. PubMed ID: 15887952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen receptor ligands. Part 6: Synthesis and binding affinity of dihydrobenzodithiins.
    Tan Q; Birzin ET; Chan W; Yang YT; Pai LY; Hayes EC; DaSilva CA; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3753-5. PubMed ID: 15203156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and evaluation of fragment-like estrogen receptor tetrahydroisoquinoline ligands from a scaffold-detection approach.
    Möcklinghoff S; van Otterlo WA; Rose R; Fuchs S; Zimmermann TJ; Dominguez Seoane M; Waldmann H; Ottmann C; Brunsveld L
    J Med Chem; 2011 Apr; 54(7):2005-11. PubMed ID: 21381753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 4: functionalization of the benzopyran A-ring.
    Norman BH; Richardson TI; Dodge JA; Pfeifer LA; Durst GL; Wang Y; Durbin JD; Krishnan V; Dinn SR; Liu S; Reilly JE; Ryter KT
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5082-5. PubMed ID: 17662603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and crystal structure of a phosphorylated estrogen receptor ligand binding domain.
    Möcklinghoff S; Rose R; Carraz M; Visser A; Ottmann C; Brunsveld L
    Chembiochem; 2010 Nov; 11(16):2251-4. PubMed ID: 20922740
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis of anthranylaldoxime derivatives as estrogen receptor ligands and computational prediction of binding modes.
    Tuccinardi T; Bertini S; Martinelli A; Minutolo F; Ortore G; Placanica G; Prota G; Rapposelli S; Carlson KE; Katzenellenbogen JA; Macchia M
    J Med Chem; 2006 Aug; 49(16):5001-12. PubMed ID: 16884312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tamoxifen and raloxifene differ in their functional interactions with aspartate 351 of estrogen receptor alpha.
    Dayan G; Lupien M; Auger A; Anghel SI; Rocha W; Croisetière S; Katzenellenbogen JA; Mader S
    Mol Pharmacol; 2006 Aug; 70(2):579-88. PubMed ID: 16679488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oestrogen receptors and selective oestrogen receptor modulators: molecular and cellular pharmacology.
    Nilsson S; Koehler KF
    Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):15-25. PubMed ID: 15667591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen receptor beta selective ligands: discovery and SAR of novel heterocyclic ligands.
    Chesworth R; Wessel MD; Heyden L; Mangano FM; Zawistoski M; Gegnas L; Galluzzo D; Lefker B; Cameron KO; Tickner J; Lu B; Castleberry TA; Petersen DN; Brault A; Perry P; Ng O; Owen TA; Pan L; Ke HZ; Brown TA; Thompson DD; DaSilva-Jardine P
    Bioorg Med Chem Lett; 2005 Dec; 15(24):5562-6. PubMed ID: 16219463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of oestrogen receptors alpha and beta during the period of uterine receptivity in rat: effect of ormeloxifene, a selective oestrogen receptor modulator.
    Awasthi S; Blesson CS; Dwivedi A
    Acta Physiol (Oxf); 2007 Jan; 189(1):47-56. PubMed ID: 17280556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that estrogen directly and indirectly modulates C1 adrenergic bulbospinal neurons in the rostral ventrolateral medulla.
    Wang G; Drake CT; Rozenblit M; Zhou P; Alves SE; Herrick SP; Hayashi S; Warrier S; Iadecola C; Milner TA
    Brain Res; 2006 Jun; 1094(1):163-78. PubMed ID: 16696957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen receptor ligands: a patent review update.
    Paterni I; Bertini S; Granchi C; Macchia M; Minutolo F
    Expert Opin Ther Pat; 2013 Oct; 23(10):1247-71. PubMed ID: 23713677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.